Cellular and humoral biomarkers of Bronchopulmonary Dysplasia. (February 2017)

• Record Type: Journal Article
• Authors: Lal, Charitharth Vivek; Ambalavanan, Namasivayam
• Is Part Of: Early human development. Volume 105(2017)
• Page Start: 35
• Page End: 39
• Publication Date: 2017-02
• Subjects: Bronchopulmonary Dysplasia -- Pulmonary hypertension -- Microbiome -- Biomarkers -- Systems biology; Fetus -- Periodicals; Neonatology -- Periodicals; Prenatal influences -- Periodicals; 612.65
• DOI: 10.1016/j.earlhumdev.2016.12.003
• Languages: English
• ISSNs: 0378-3782

Abstract

Abstract: The pathogenesis of Bronchopulmonary Dysplasia (BPD) is multifactorial and the clinical phenotype of BPD is extremely variable. Predicting BPD is difficult, as it is a disease with a clinical operational definition but many clinical phenotypes and endotypes. Most biomarkers studied over the years have low predictive accuracy, and none are currently used in routine clinical care or shown to be useful for predicting longer-term respiratory outcome. Targeted cellular and humoral biomarkers and novel systems biology 'omic' based approaches including genomic and microbiomic analyses are described in this review.